You are viewing the site in preview mode

Skip to main content

Table 4 Characteristics of female patients with VA according to BMI

From: Sex differences in clinical characteristics and long-term outcomes in patients with vasospastic angina: results from the VA-Korea registry, a prospective multi-center cohort

Characteristic BMI < 25 kg/m2 (n = 364) BMI ≥ 25 kg/m2 (n = 303) p
Age, years 56.3 ± 10.9 57.7 ± 10.4 0.036
BMI, kg/m2 22.2 ± 1.7 27.9 ± 3.4 < 0.001
Systolic blood pressure, mmHg 124 ± 19 123 ± 17 0.634
Diastolic blood pressure, mmHg 75.4 ± 12.3 74.1 ± 10.8 0.173
Cardiovascular risk factors
 Hypertension 111 (30.5) 141 (46.5) < 0.001
 Diabetes mellitus 16 (4.4) 37 (12.2) < 0.001
 Dyslipidemia 55 (15.2) 66 (21.9) 0.026
 Current smoking 24 (6.6) 10 (3.3) 0.170
 Alcohol drinking 66 (18.1) 36 (11.9) 0.026
Clinical diagnosis
 Acute myocardial infarction 5 (1.4) 4 (1.3) 0.960
 Cardiac arrest 3 (0.8) 2 (0.7) 0.999
 Syncope 2 (0.5) 2 (0.7) 0.999
 Ventricular tachycardia or fibrillation 2 (0.5) 1 (0.3) 0.999
Significant atherosclerosis 29 (8.0) 27 (9.0) 0.642
Definite spasm 88 (24.2) 83 (27.4) 0.343
Laboratory findings
 Hemoglobin, g/dL 12.7 ± 1.2 12.9 ± 1.2 0.147
 GFR, mL/min/1.73 m2 104 ± 48 100 ± 29 0.136
 Glucose, mg/dL 105 ± 38 107 ± 31 0.502
 Total cholesterol, mg/dL 178 ± 34 177 ± 37 0.710
 LDL cholesterol, mg/dL 105 ± 30 107 ± 32 0.639
 HDL cholesterol, mg/dL 52.4 ± 13.7 48.0 ± 11.7 < 0.001
 Triglyceride, mg/dL 115 ± 101 132 ± 74 0.019
 Left ventricular ejection fraction, % 64.4 ± 6.2 65.2 ± 6.4 0.126
Discharge medications
 Antiplatelet 138 (38.2) 141 (46.5) 0.030
 Non-DHP calcium channel blocker 282 (77.5) 222 (73.3) 0.208
 Nitrate 281 (77.2) 241 (79.5) 0.466
 RAS blocker 45 (12.4) 56 (18.5) 0.028
 Statin 156 (42.9) 153 (50.5) 0.049
  1. Numbers are represented as mean ± SD or n (%). VA Vasospastic angina, BMI Body mass index, GFR Glomerular filtration rate, LDL Low-density lipoprotein, HDL High-density lipoprotein, DHP Non-dihydropyridine, RAS Renin-angiotensin system